The value of 18-fluorodeoxyglucose positron emission tomography in prognosis of patients with pancreatic cancer
10.3760/cma.j.issn.1007-631X.2010.11.011
- VernacularTitle:18F-FDG PET在胰腺癌患者预后评估中的价值
- Author:
Huiling WANG
;
Baohua HOU
;
Jinrui OU
- Publication Type:Journal Article
- Keywords:
Pancreatic neoplasms;
Positron-emission tomography;
Neoplasm staging
- From:
Chinese Journal of General Surgery
2010;25(11):892-894
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the value of 18F-FDG PET in predicting the prognosis of pancreatic cancer. Methods Fifty-four cases of pancreatic cancer were divided into two groups. Taking standard uptake value(SUV) at 4 as the cut off point, patients (22 cases) with that not more than four were classified into group A, and those (32 cases) with SUV greater than four were into group B. The prognosis of patients by SUV was analyzed statistically. Results There was a statistically significant difference in survival between the two groups ( P =0. 01 ). The 1-,3-year survival rate was 68. 18% 、34. 91% in group A in those the SUV≤4, and 33.61% 、11.95% in group B( SUV >4), respectively. Cox proportional hazard model showed that tumor staging and SUV were the significantly independent prognostic factors in patients with pancreatic cancer. Conclusions 18F-FDG PET is of value in predicting the prognosis of patients with pancreatic cancer.